Soul Searching and Deep Thinking – A Socratic Moment

Mike Magee You can say what you want about America’s current trajectory, but one thing’s for sure – there’s a lot of soul searching and deep thinking going on. Just this morning, I came across three different pieces – in The New Yorker, the New England Journal of Medicine, and the The New York Times – […]

Global Burden of Disease Update – U.S. Mortality 58th.

Lancet Interactive HERE The Lancet just updated Christopher Murray’s longitudinal study on Global Burden of Disease. Now entering its 20th year, it continues to show the advance of chronic disease over communicable disease as a source of mortality and morbidity(in 3 out of 4 cases). In the latest rankings, the US finished 24th overall […]

Academic Medicine – What’s To Become of the Triple Mission Under Universal Health Care?

Hopkins Alumni Careers 1980-2012. Mike Magee A New York Times banner headline in 2016 read, “Harnessing the U.S. Taxpayer to Fight Cancer and Make Profits”. It documented the unusual partnership between Kite Pharma, a cancer immunotherapy start-up run by serial entrepreneur, Arie Nelldegrun, and the U.S. government. The underlying immunotherapy research was the […]

Pharma Patents – A Good Bet For Casino Heavy Native Americans.

The Latest Pharma Campus? Mike Magee In the immediate aftermath of WW II, the U.S. government decided to join hands with industry and academia and fund a campaign to “defeat disease” as they had defeated the Nazi’s. Defeat disease and health will be left in its wake was the thinking of the day. What they […]

Do You Know Who Your Insurance Commissioner Is?

Who’s My Insurance Commissioner – and was she/he elected or appointed? Find Out HERE.

The Changing U.S. Workforce

With U.S. health care now consuming nearly 20% of a GDP, and somewhere between $4 and $5 trillion annually, its not surprising that jobs in the health field are exploding as well. But for every one US physician, 16 others are employed in non-clinical health care jobs. But American jobs aren’t what they were three […]

Compounding Our Weaknesses – Gray Market Drug Collusion.

Mike Magee In the realm of pharmaceutical disaster deja vu, Tennessee deserves special recognition. In early September, 1937, the S.E. Massengill Company of Bristol, Tennessee, distributed tainted elixir of sulfanilamide nationwide. Before the disaster ended, 104 patients, most of them children, had died. Nearly 80 years latter to the date, Dr. April Petit put in […]

keep looking »